Research Articles
Sabotaging the Sentinel: How Adenovirus Hijacks the Cell's DNA Damage Alarm
Explore how adenoviruses disrupt the cellular DNA Damage Response (DDR) pathway to enable viral replication, with implications for cancer therapy.
The Stealth Saboteur: How Pancreatic Cancer Hijacks Muscle Maintenance via IGFBP-3
Groundbreaking research reveals how tumor-derived IGFBP-3 drives muscle wasting in pancreatic cancer patients through metabolic hijacking.
The Double Life of HIF-1α: How Cellular Survival Mechanisms Turn Traitor
Exploring how HIF-1α's survival mechanisms can become pathological when activated by TOR and SMAD pathways in cancer, autoimmunity, and fibrosis.
BAP1: The Unsung Hero in Lung Cancer's Molecular Battlefield
Exploring BAP1's role as a prognostic biomarker and therapeutic target in non-small cell lung cancer (NSCLC)
The Hidden Conductor: How a Tiny RNA Steers Stem Cell Destiny
Discover how the lncRNA ESRG regulates TCF3 alternative splicing to maintain human embryonic stem cell pluripotency and self-renewal.
The Lipid Linchpin: How a Metabolic Mastermind Fuels Lung Cancer's Deadliest Cells
Exploring how SCD1's manipulation of cellular architecture through YAP/TAZ fuels lung cancer stem cells and drives recurrence.
The Silent Cleanup Crew: How Autophagy Gone Wrong Sparks Animal Diseases
Exploring how dysfunctional autophagy contributes to neurodegenerative disorders, metabolic diseases, and inflammatory conditions in animals.
Decoding the Cell's Ubiquitin Language: How Chemical Tools Are Cracking a Biological Cipher
Exploring how chemical biology is unlocking the secrets of ubiquitination, the cellular 'kiss of death' that regulates protein fate and function.
The Silent Guardian: How Cells Shut Down Genes to Fix Broken DNA
Discover how BRD7 protein orchestrates transcriptional repression to enable DNA repair at active gene regions, a breakthrough in genome maintenance research.
Double Blockade: How Dual-Targeted Therapy is Outsmarting Aggressive Leukemia
Exploring the synergistic combination of FLT3 inhibitors and BH3 mimetics in treating FLT3-ITD Acute Myeloid Leukemia